Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
PROVENGE Significantly Prolongs Survival in Men with Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study. – Dendreon Corporation (Nasdaq: DNDN) announced that the pivotal Phase 3 IMPACT study of PROVENGE (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control.
Omega-3 fatty acids reduce risk of advanced prostate cancer – Omega-3 fatty acids appear protective against advanced prostate cancer, and this effect may be modified by a genetic variant in the COX-2 gene, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
New international research has linked heavier drinking and prostate cancer. – An international research team from Australia, Canada and the United States found that men who drank two or more standard drinks of alcohol a day are more likely to develop prostate cancer.
Red wine vs. white? It makes no difference when it comes to breast-cancer risk – The largest study of its kind to evaluate the effect of red versus white wine on breast-cancer risk concludes that both are equal offenders when it comes to increasing breast-cancer risk.
A first degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients. – Family history of prostate cancer does not affect some prostate cancer patient’s treatment outcomes, revealed by researchers.
Grape seed extract kills laboratory leukemia cells, proving value of natural compounds. – An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.
Low income men more likely to be diagnosed with advanced prostate cancer – Low-income men are more likely to present with advanced prostate cancers, most likely because they don’t receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.
Men with wives, significant others more likely to be screened for prostate cancer – Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
One-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year. – In one of the first examinations of PSA screening in younger men, a study published by researchers at Duke Medicine’s Prostate Center finds that one-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year.
US Preventive Services Task Force updates prostate cancer screening recommendations; Task Force finds no screening benefit for men over 75. – The U.S. Preventive Services Task Force (USPSTF), updating its 2002 report, now recommends against routine prostate cancer screening for men over the age of 75. More evidence is needed to determine if men under 75 could benefit from screening.
